Sagimet Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Sagimet Biosciences's balance sheet done over the years? Its assets were worth $96,719,000 last year, which is more than in the previous period. 6% of Sagimet Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $5,654,000, which means an decrease by -97% compared compared to last year.

Debt to Assets

Sagimet Biosciences Inc. (NASDAQ:SGMT): Debt to assets
2019 11160000 136.47M 1222.89%
2020 68959000 204.86M 297.09%
2021 59032000 217.29M 368.09%
2022 33031000 219.98M 665.98%
2023 96719000 5.65M 5.85%

SGMT Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
75.13M158K56.73M68.70M10.21M
Short term investments
19.75M32.18M000
Net receivables
00000
Inventory
00000
Other current assets
1.74M95K84K36K58K
Total current assets
96.64M32.79M58.66M68.73M10.81M
Non-current assets:
Property, Plant and Equipment
73K212K342K194K318K
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
027K27K27K27K
Total non-current assets
73K239K369K221K345K
Total assets
96.71M33.03M59.03M68.95M11.16M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
03.96M1.37M1.00M0
Short term debt
130K133K124K145K130K
Total current liabilities
5.65M5.27M2.44M1.91M2.07M
Non-current liabilities:
Long term debt
078K224K65K211K
Deferred tax
00000
Other non-current liabilities
0214.62M214.62M202.89M134.18M
Total non-current liabilities
0214.70M214.85M202.95M134.39M
Total liabilities
5.65M219.98M217.29M204.86M136.47M
Data source